Skip to content

DiaMedica Therapeutics Inc.

DMAC· NasdaqCore metricsCIK 1401040

Pharmaceutical preparations553 peers

Last sale
Nov 12, 2026 · -2.95%
Market cap
$505.58M
53.96M shares
Filings
429
$500.00K
FY 2018
—
-$11.31M
Q3 2026N/M FY25 yoy
-$11.62M
Q3 2026N/M FY25 yoy
-$26.05M
Q3 2026derivedN/M FY25 yoy
-$0.65
FY 2021N/M FY21 yoy
$6.80M
Q3 2026+417.3% FY25 yoy
$505.58M
—
—
17.6×
-5.76%
—

FY2025 figures · derived

Price

$9.37+46.64%+$2.98past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$500.00KFY 2018
$500.00K0FY 2018
PeriodEndedValueKindSource trail
FY 20182018-12-31$500,000reported

Pharmaceutical preparations

DiaMedica Therapeutics Inc. is the 182nd largest of the 554 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

DiaMedica Therapeutics Inc. · CIK 1401040 · Engraved from SEC EDGAR